Xiao Tan is a Gastroenterology physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
55 Fruit Street
Blake 4
Boston, MA 02114
Telephone
617-643-6361Registry record last updated 15 May 2019.
Clinical trials
- Sequences of Aerobic and Resistance Exercise and Cardio-metabolic Functions in T2D
Sponsor: Zhejiang University
- The Effect of Blood Flow Restriction Training on Glycemic Control Among Type 2 Diabetes Patients
Sponsor: Uppsala University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Osmotic Laxative45.1%Gavilyte-G100%Part D≥45 patientsProton pump inhibitor36.3%Omeprazole100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2023–2026 per NIH RePORTER. The latest:
- Machine learning-based methods for the analysis of microbial glycomes and proteomes in inflammatory bowel disease.
Massachusetts General Hospital
FY2026$169,560K08DK132516 - Machine learning-based methods for the analysis of microbial glycomes and proteomes in inflammatory bowel disease.
Massachusetts General Hospital
FY2025$169,560K08DK132516 - Machine learning-based methods for the analysis of microbial glycomes and proteomes in inflammatory bowel disease.
Massachusetts General Hospital
FY2024$169,560K08DK132516
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Josep M. Llovet
Institució Catalana de Recerca i Estudis Avançats
Joseph J.�Y. Sung
Nanyang Technological University
Neeraj Bhala
The Royal Melbourne Hospital
Jordi Bruix
Hospital Clínic de Barcelona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”